Coronavirus vaccine: Russia moves a step ahead of China with clinical trial data release

A peer review of data has boosted the credibility of a Russian-made coronavirus vaccine dogged by transparency concerns, raising hopes that the shot can help ease global shortages, according to medical specialists.The assessment comes after The Lancet medical journal published results on Tuesday indicating that the Sputnik V vaccine had an efficacy rate of nearly 92 per cent against Covid-19.The Lancet article was based on an interim analysis of a trial involving nearly 20,000 people in Russia…

Read the original article at South China Morning Post